Pneumothorax with CC DRG Payment Rates & Reimbursement

DRG 200 encompasses inpatient cases of pneumothorax with a Complication or Comorbidity, covering treatment modalities like chest tube management and monitoring for respiratory compromise. Correct assignment matters for inpatient reimbursement because the Diagnosis-Related Group captures higher resource use and influences Medicare payment levels.

DRG 200 Overview

DRG 200 covers inpatient admissions for pneumothorax with a Complication or Comorbidity and includes cases requiring management such as chest tube placement, observation for recurrent collapse, or treatment of associated respiratory compromise. This Diagnosis-Related Group groups patients with added clinical complexity compared with uncomplicated pneumothorax, which affects resource use during hospitalization. Payment under Medicare for this Diagnosis-Related Group reflects that increased intensity of care and potential for longer length of stay. Accurate coding of comorbid conditions and procedures impacts Medicare Severity Diagnosis-Related Group assignment and subsequent reimbursement.

Acute interventional trials evaluating different methods of emergent pneumothorax management: randomized or pragmatic studies comparing immediate bedside needle aspiration, small-bore chest tube placement, and large-bore tube thoracostomy in adult inpatients with primary or secondary spontaneous pneumothorax complicated by respiratory compromise or hemodynamic instability. These studies focus on the initial 24–72 hour inpatient period and enroll patients with clinically significant air leak, tension physiology, or CC-level comorbidities (for example underlying COPD, recent mechanical ventilation, or anticoagulation). Results inform best-practice algorithms for rapid stabilization, resource utilization (ICU vs ward), and short-term outcomes that are directly relevant to clinicians making urgent management decisions and to payers concerned with length of stay and procedure-related costs.
Comparative effectiveness research on pleural drainage strategies and hospital course optimization: non-randomized registry analyses or randomized trials comparing approaches such as ambulatory small-bore catheter with one-way valve versus inpatient inpatient chest tube with hospital observation, and studies assessing timing of suction, use of chemical pleurodesis, or criteria for surgical referral. These trials enroll patients who are medically stable after initial decompression but have persistent air leak or high readmission risk due to comorbid conditions; they evaluate outcomes including length of stay, readmission rates, resolution of pneumothorax, and complications. Findings guide inpatient pathways and discharge planning that affect resource allocation, readmission penalties, and payer case-mix management for the DRG population.
Post-discharge outcomes and prevention studies targeting recurrence and chronic complications: cohort studies and pragmatic interventions that follow patients after hospital discharge to assess rates of recurrent pneumothorax, long-term pulmonary function, quality of life, and the impact of comorbidity management (for example COPD optimization, smoking cessation, or anticoagulation review). These studies often include patients with CC-level comorbidities who are at higher risk for recurrence and downstream utilization; they test care coordination strategies, outpatient monitoring protocols, and referral thresholds for elective surgical pleurodesis or bullectomy. Results are important to providers and payers because reducing recurrence and downstream admissions can lower total episode costs and improve long-term outcomes for patients categorized under this DRG.

Acute interventional trials evaluating different methods of emergent pneumothorax management: randomized or pragmatic studies comparing immediate bedside needle aspiration, small-bore chest tube placement, and large-bore tube thoracostomy in adult inpatients with primary or secondary spontaneous pneumothorax complicated by respiratory compromise or hemodynamic instability. These studies focus on the initial 24–72 hour inpatient period and enroll patients with clinically significant air leak, tension physiology, or CC-level comorbidities (for example underlying COPD, recent mechanical ventilation, or anticoagulation). Results inform best-practice algorithms for rapid stabilization, resource utilization (ICU vs ward), and short-term outcomes that are directly relevant to clinicians making urgent management decisions and to payers concerned with length of stay and procedure-related costs.
Comparative effectiveness research on pleural drainage strategies and hospital course optimization: non-randomized registry analyses or randomized trials comparing approaches such as ambulatory small-bore catheter with one-way valve versus inpatient inpatient chest tube with hospital observation, and studies assessing timing of suction, use of chemical pleurodesis, or criteria for surgical referral. These trials enroll patients who are medically stable after initial decompression but have persistent air leak or high readmission risk due to comorbid conditions; they evaluate outcomes including length of stay, readmission rates, resolution of pneumothorax, and complications. Findings guide inpatient pathways and discharge planning that affect resource allocation, readmission penalties, and payer case-mix management for the DRG population.
Post-discharge outcomes and prevention studies targeting recurrence and chronic complications: cohort studies and pragmatic interventions that follow patients after hospital discharge to assess rates of recurrent pneumothorax, long-term pulmonary function, quality of life, and the impact of comorbidity management (for example COPD optimization, smoking cessation, or anticoagulation review). These studies often include patients with CC-level comorbidities who are at higher risk for recurrence and downstream utilization; they test care coordination strategies, outpatient monitoring protocols, and referral thresholds for elective surgical pleurodesis or bullectomy. Results are important to providers and payers because reducing recurrence and downstream admissions can lower total episode costs and improve long-term outcomes for patients categorized under this DRG.

OpenPayer

Summary & Overview

Pneumothorax with CC: Inpatient Reimbursement Overview

DRG 200 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes